In the TCGA CCA cohort, high expression of IL6, TNF, AKT1, and STAT3 and low expression of PPARG correlated with advanced tumor stage and poorer overall survival (e.g., IL6: ρ = 0.42, <i>p</i> = 0.01). The gene discussed is AKT1; the disease is cholangiocarcinoma.